Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Prostate Cancer

Free Subscription Articles published in Cancer Imaging Retrieve available abstracts of 27 articles: HTML format

Single Articles

July 2025
1. YANG L, Jin P, Wang X, Li Z, et al
   Development and validation of a novel clinical-radiological-pathological scoring system for preoperative prediction of extraprostatic extension in prostate cancer: a multicenter retrospective study.
   Cancer Imaging. 2025;25:83.
   PubMed     Abstract available
   
   
   June 2025
2. BIAN L, Liu F, Peng Y, Liu X, et al
   Using radiomics model for predicting extraprostatic extension with PSMA PET/CT studies: a comparative study with the Mehralivand grading system.
   Cancer Imaging. 2025;25:77.
   PubMed     Abstract available
   
   
   April 2025
3. MOAVENZADEH SR, Chan DY, Adams ES, Deivasigamani S, et al
   Evaluation of 3D ARFI imaging of prostate cancer: diagnostic reliability and concordance with MpMRI.
   Cancer Imaging. 2025;25:55.
   PubMed     Abstract available
   
   
   
4. ZEDAN AH, Gade JS, Zieger KEA, Poulsen MH, et al
   Cabazitaxel-induced ureteritis in metastatic castration-resistant prostate cancer patients: a single center case series 2014-2024.
   Cancer Imaging. 2025;25:54.
   PubMed     Abstract available
   
   
   March 2025
5. SUN Z, Wu P, Zhao T, Gao G, et al
   Deep learning-based fully automated detection and segmentation of pelvic lymph nodes on diffusion-weighted images for prostate cancer: a multicenter study.
   Cancer Imaging. 2025;25:37.
   PubMed     Abstract available
   
   
   
6. POROES F, Karampa P, Sartoretti T, Najberg H, et al
   Additional findings in prostate MRI.
   Cancer Imaging. 2025;25:29.
   PubMed     Abstract available
   
   
   January 2025
7. HUANG X, Ye H, Hu Y, Lei Y, et al
   Ultrasound super-resolution imaging for non-invasive assessment of microvessel in prostate lesion.
   Cancer Imaging. 2025;25:1.
   PubMed     Abstract available
   
   
   October 2024
8. BURGARD C, Rosar F, Larsen E, Khreish F, et al
   Outstanding increase in tumor-to-background ratio over time allows tumor localization by [(89)Zr]Zr-PSMA-617 PET/CT in early biochemical recurrence of prostate cancer.
   Cancer Imaging. 2024;24:132.
   PubMed     Abstract available
   
   
   September 2024
9. VENTURA D, Rassek P, Schindler P, Akkurt BH, et al
   Early treatment response assessment with [(177)Lu]PSMA whole-body-scintigraphy compared to interim PSMA-PET.
   Cancer Imaging. 2024;24:126.
   PubMed     Abstract available
   
   
   August 2024
10. HARSINI S, Martineau P, Plaha S, Saprunoff H, et al
    Prognostic significance of a negative PSMA PET/CT in biochemical recurrence of prostate cancer.
    Cancer Imaging. 2024;24:117.
    PubMed     Abstract available
    
    
    
11. XU L, Peng Q, Zhang G, Zhang D, et al
    Development of preoperative nomograms to predict the risk of overall and multifocal positive surgical margin after radical prostatectomy.
    Cancer Imaging. 2024;24:104.
    PubMed     Abstract available
    
    
    July 2024
12. FURMAN B, Falick Michaeli T, Den R, Ben Haim S, et al
    Pelvic lymph node mapping in prostate cancer: examining the impact of PSMA PET/CT on radiotherapy decision-making in patients with node-positive disease.
    Cancer Imaging. 2024;24:96.
    PubMed     Abstract available
    
    
    
13. KALLIS K, Conlin CC, Zhong AY, Hussain TS, et al
    Comparison of synthesized and acquired high b-value diffusion-weighted MRI for detection of prostate cancer.
    Cancer Imaging. 2024;24:89.
    PubMed     Abstract available
    
    
    
14. YANG J, Xiao L, Zhou M, Li Y, et al
    [(68)Ga]Ga?PSMA?617 PET-based radiomics model to identify candidates for active surveillance amongst patients with GGG 1-2 prostate cancer at biopsy.
    Cancer Imaging. 2024;24:86.
    PubMed     Abstract available
    
    
    
15. GROSS M, Eisenhuber E, Assinger P, Schima R, et al
    MRI-guided in-bore biopsy of the prostate - defining the optimal number of cores needed.
    Cancer Imaging. 2024;24:81.
    PubMed     Abstract available
    
    
    May 2024
16. AYATI N, McIntosh L, Buteau J, Alipour R, et al
    Comparison of quantitative whole body PET parameters on [(68)Ga]Ga-PSMA-11 PET/CT using ordered Subset Expectation Maximization (OSEM) vs. bayesian penalized likelihood (BPL) reconstruction algorithms in men with metastatic castration-resistant prosta
    Cancer Imaging. 2024;24:57.
    PubMed     Abstract available
    
    
    April 2024
17. KOLADE OU, Brink A, Ayeni AO, More S, et al
    Optimizing PSMA scintigraphy for resource limited settings - a retrospective comparative study.
    Cancer Imaging. 2024;24:46.
    PubMed     Abstract available
    
    
    February 2024
18. YAZDANI E, Karamzadeh-Ziarati N, Cheshmi SS, Sadeghi M, et al
    Automated segmentation of lesions and organs at risk on [(68)Ga]Ga-PSMA-11 PET/CT images using self-supervised learning with Swin UNETR.
    Cancer Imaging. 2024;24:30.
    PubMed     Abstract available
    
    
    
19. ROSAR F, Burgard C, Larsen E, Khreish F, et al
    [(89)Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [(68)Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis.
    Cancer Imaging. 2024;24:27.
    PubMed     Abstract available
    
    
    
20. GUERRA A, Orton MR, Wang H, Konidari M, et al
    Clinical application of machine learning models in patients with prostate cancer before prostatectomy.
    Cancer Imaging. 2024;24:24.
    PubMed     Abstract available
    
    
    
21. HU C, Qiao X, Hu C, Cao C, et al
    The practical clinical role of machine learning models with different algorithms in predicting prostate cancer local recurrence after radical prostatectomy.
    Cancer Imaging. 2024;24:23.
    PubMed     Abstract available
    
    
    January 2024
22. MA Y, Gao F
    Advances of radiolabeled GRPR ligands for PET/CT imaging of cancers.
    Cancer Imaging. 2024;24:19.
    PubMed     Abstract available
    
    
    December 2023
23. DONNERS R, Figueiredo I, Westaby D, Koh DM, et al
    Multiparametric bone MRI targeting aides lesion selection for CT-guided sclerotic bone biopsies in metastatic castrate resistant prostate cancer.
    Cancer Imaging. 2023;23:121.
    PubMed     Abstract available
    
    
    November 2023
24. PENG Q, Xu L, Zhang G, Zhang D, et al
    Effect of preoperative PI-RADS assessment on pathological outcomes in patients who underwent radical prostatectomy.
    Cancer Imaging. 2023;23:113.
    PubMed     Abstract available
    
    
    
25. LUO L, Zheng A, Chang R, Li Y, et al
    Evaluating the value of (18)F-PSMA-1007 PET/CT in the detection and identification of prostate cancer using histopathology as the standard.
    Cancer Imaging. 2023;23:108.
    PubMed     Abstract available
    
    
    September 2023
26. HU B, Zhang H, Zhang Y, Jin Y, et al
    A nomogram based on biparametric magnetic resonance imaging for detection of clinically significant prostate cancer in biopsy-naive patients.
    Cancer Imaging. 2023;23:82.
    PubMed     Abstract available
    
    
    
27. YANG J, Li J, Xiao L, Zhou M, et al
    (68)Ga-PSMA PET/CT-based multivariate model for highly accurate and noninvasive diagnosis of clinically significant prostate cancer in the PSA gray zone.
    Cancer Imaging. 2023;23:81.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.